Viropharma Incorporated Company Profile

Aggregated data from the web about Viropharma Incorporated

Company Name	Viropharma Incorporated
Website	https://en.wikipedia.org
Snippet	ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire ...
Type	Public NASDAQ Biotechnology Index
Defunct	2014
Founded	1994
Founder	Claude H. NashMark A. McKinlayMarc S. CollettJohanna A. GriffinGuy D. Diana
Revenue	132,417,000 USD (2005)
Website	www.viropharma.com
Industry	Healthcare, Biotechnology, Pharmaceutical company
Products	Vancocin
Traded as	NASDAQ: VPHM
Key people	Vincent Milano(Chairman and CEO)
Net income	113,705,000 USD (2005)
Headquarters	Exton, Pennsylvania, U.S.
Operating income	88,145,000 USD (2005)
Number of employees	232[1]

Viropharma Incorporated is part of the United States company list

Viropharma Incorporated is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.